Corporate Update – Kwang Dong Pharmaceutical (009290.KS)

Kwang Dong Pharmaceutical (009290.KS) closed 0.6 % lower during the 24‑hour period ending at 12:19 PM Central Europe on Monday, 26 November 2026. The share price was reported at KRW 6,450 on major exchanges.

The current supply of shares is 49.7 million, and the market capitalisation stands at KRW 327.5 billion. In the last 24 hours, the stock was traded for a total value of approximately KRW 747.7 million.

Since the close of the previous month, the stock has increased by 0.61 %. The simple moving average over the last 200 days is KRW 6,934.8. The 52‑week high was KRW 12,800 on 23 February 2026, and the 52‑week low was KRW 5,150 on 26 June 2026.

  • Socar (403550.KS) – Up 1.59 %, trading at KRW 10,070; market cap KRW 385.2 billion.
  • Samyang (000070.KS) – Down 0.94 %, trading at KRW 51,600; market cap KRW 375.6 billion.
  • Kc (029460.KS) – Up 0.14 %, trading at KRW 33,250; market cap KRW 374.4 billion; price‑to‑earnings ratio 7.83.
  • Iljin Hysolus (271940.KS) – Down 2.53 %, trading at KRW 10,520; market cap KRW 391.5 billion.

Company Profile

Kwang Dong Pharmaceutical Co., Ltd. is headquartered in Seoul, Korea, and operates in the healthcare sector. The company develops and manufactures herbal‑based medicines and foods, including prescription drugs, health drinks, and nutrient supplements. More information is available on the company’s website at www.ekdp.com . The company is listed on the Korea Exchange Stock Market.